Australia: Safety advisory: LIPRO Dietary capsules contain the undeclared substances sibutramine and diphenhydramine (English Only)
 
The Therapeutic Goods Administration (TGA) has tested a product labelled LIPRO Dietary capsules and found that the capsules contain the undeclared substances sibutramine and diphenhydramine. Consumers are advised that sibutramine is a prescription-only substance in Australia. Sibutramine (which was the active ingredient in Reductil) was withdrawn in Oct 2010 after a study showed an increased risk of major cardiac events. Diphenhydramine is a pharmacy only substance and used as an antihistamine. TGA investigations have shown that a number of people in Australia may have bought the product online. 

Consumers are advised to stop taking the product and take any remaining capsules to their local pharmacy for safe disposal. If they have any concerns arising from their use of this product, consult their health care practitioner. 

Please refer to the following website in TGA for details: http://www.tga.gov.au/alert/lipro-dietary-capsules 

In Hong Kong, the above product is not a registered pharmaceutical product. 

Ends/Wednesday, Apr 18, 2018 
Issued at HKT 15:00 

轉載自衛生署藥物辦公室網頁http://www.drugoffice.gov.hk/